Stimulant Meds For AD/HD Not Tied To Height Deficits In Adulthood

The NPR (9/2, Hobson) “Shots” blog reported that, according to the results of a 340-patient study published online Sept. 1 in the journal Pediatrics, taking stimulant medications for attention-deficit/hyperactivity disorder (AD/HD) in childhood appears not to lead to “height deficits in adulthood.”

HealthDay (9/3, Reinberg) reports that the study’s lead author “said this study is unique because it followed a group of people with AD/HD who were taking stimulant medications and compared them with a group with AD/HD who were not taking medication and also a group that didn’t have AD/HD.” All participants “were followed from childhood to adulthood, she said.” HealthDay also notes, “AD/HD is one of the most common disorders of childhood, according to the US National Institute of Mental Health (NIMH).”

Related Links:

— “More Evidence That ADHD Drugs Don’t Curb Ultimate Height,” Katherine Hobson, National Public Radio, September 1, 2014.

Posted in In The News.